Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease
Cameron S. McAlpine(Icahn School of Medicine at Mount Sinai), Filip K. Świrski(Allen Institute for Brain Science), Wolfram C. Poller(Icahn School of Medicine at Mount Sinai), Henrike Janssen(Harvard University), Paolo Fumene Feruglio(University of Verona), Claudio Vinegoni(Harvard University), Yoshiko Iwamoto(Harvard University), Florian Kahles(Universitätsklinikum Aachen), Máté G. Kiss(Austrian Academy of Sciences), Rudolph E. Tanzi(Harvard University), Jeffrey Downey(Icahn School of Medicine at Mount Sinai), Benjamin P. Kleinstiver(Harvard University), Se Hoon Choi(MaineGeneral Medical Center), Ralph Weissleder(Massachusetts General Hospital), John E. Mindur(Harvard University), Matthias Nahrendorf(Massachusetts General Hospital), Mehdi Jorfi(Harvard University), Kathleen A. Christie(Harvard University), Sumnima Singh(Harvard University), Atsushi Anzai(Keio University), Eunhee Kim(Massachusetts General Hospital), Joseph Park(University of Pennsylvania), Shun He(Harvard University), Christopher T. Chan(Harvard University), Ana Griciuc(Massachusetts General Hospital), Lai Ping Wong(Harvard University), Ruslan I. Sadreyev(Harvard University)
Cited by 330
Related Papers
A clearer vision for in vivo imaging
|Nature Biotechnology|2001|3.8k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
A polymorphic DNA marker genetically linked to Huntington's disease
|Nature|1983|2.3k
Imaging in the era of molecular oncology
|Nature|2008|2.3k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k